Stock Analysis
- Canada
- /
- Healthcare Services
- /
- TSXV:EBM
Eastwood Bio-Medical Canada Second Quarter 2024 Earnings: CA$0.002 loss per share (vs CA$0.003 loss in 2Q 2023)
Eastwood Bio-Medical Canada (CVE:EBM) Second Quarter 2024 Results
Key Financial Results
- Revenue: CA$135.2k (down 38% from 2Q 2023).
- Net loss: CA$130.1k (loss narrowed by 26% from 2Q 2023).
- CA$0.002 loss per share (improved from CA$0.003 loss in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Eastwood Bio-Medical Canada shares are down 50% from a week ago.
Risk Analysis
Before you take the next step you should know about the 4 warning signs for Eastwood Bio-Medical Canada (3 are potentially serious!) that we have uncovered.
Valuation is complex, but we're helping make it simple.
Find out whether Eastwood Bio-Medical Canada is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're helping make it simple.
Find out whether Eastwood Bio-Medical Canada is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About TSXV:EBM
Eastwood Bio-Medical Canada
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia.
Low with imperfect balance sheet.